Assertio Therapeutics Inc (ASRT) — Cash Flow Quality Index
Assertio Therapeutics Inc (ASRT) has a Cash Flow Quality Index of -0.42x as of September 2025. Operating cash flow of $-4.77 Million is below net income of $11.45 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Assertio Therapeutics Inc cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Assertio Therapeutics Inc Cash Flow Quality Index (2007–2022)
Historical Cash Flow Quality Index for Assertio Therapeutics Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Assertio Therapeutics Inc (ASRT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Assertio Therapeutics Inc (2007–2022)
Year-by-year earnings quality comparison for Assertio Therapeutics Inc. For live market cap and the full company financial profile, see ASRT market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.72x | $78.60 Million | $109.62 Million | ▼ -63.5% |
| 2018 | 1.96x | $72.50 Million | $36.91 Million | ▲ +407.7% |
| 2013 | 0.39x | $9.75 Million | $25.21 Million | ▼ -52.5% |
| 2011 | 0.82x | $57.65 Million | $70.73 Million | ▲ +233.4% |
| 2010 | -0.61x | $-2.38 Million | $3.90 Million | ▼ -305.2% |
| 2007 | 0.30x | $14.66 Million | $49.22 Million | — |